Webinar

In this session, leading cell therapy CDMOs will break down how they support programs across development—from early process work through GMP manufacturing, scale-up, and commercial readiness—and where different approaches can reduce downstream risk or introduce it. This is a focused look at who does what, and where they fit—so you can evaluate partners with greater...

In this session, leading CDMO experts will break down the key decisions across host cell selection, vector design, and clone screening strategies, and explain how those choices impact expression, scalability, and long-term manufacturability. These presentations will highlight how different CDMO approaches can reduce downstream risk or introduce it, as programs move from early development into...